Clinical Trial Update: Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC [Phase 2]

View source ↗

Summary

This entry covers a Phase 2 clinical trial evaluating low-dose trifluridine/tipiracil in combination with bevacizumab for metastatic colorectal cancer, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• trifluridine/tipiracil (trifluridine/tipiracil)

Snippet

Sponsor: Ruijin Hospital | Conditions: Colo-rectal Cancer, Third-line and Beyond Therapy | Phase 2 | Status: RECRUITING